The ubiquitin-proteasome pathway in cancer
Open Access
- 1 February 1998
- journal article
- review article
- Published by Springer Nature in British Journal of Cancer
- Vol. 77 (3) , 448-455
- https://doi.org/10.1038/bjc.1998.71
Abstract
No abstract availableKeywords
This publication has 96 references indexed in Scilit:
- Mdm2 promotes the rapid degradation of p53Nature, 1997
- Structure of 20S proteasome from yeast at 2.4Å resolutionNature, 1997
- Enhancement of CPP32-like Activity in the TNF-Treated U937 Cells by the Proteasome InhibitorsBiochemical and Biophysical Research Communications, 1996
- Ligand-Activated Platelet-Derived Growth Factor β-Receptor Is Degraded through Proteasome-Dependent Proteolytic PathwayBiochemical and Biophysical Research Communications, 1995
- Lactacystin, a Specific Inhibitor of the Proteasome, Induces Apoptosis in Human Monoblast U937 CellsBiochemical and Biophysical Research Communications, 1995
- LMP2+ proteasomes are required for the presentation of specific antigens to cytotoxic T lymphocytesCurrent Biology, 1995
- Proteolysis: The proteasome: a protein-degrading organelle?Current Biology, 1995
- cDNA Cloning of p40, a Regulatory Subunit of the Human 26S Proteasome, and a Homolog of the Mov-34 Gene ProductBiochemical and Biophysical Research Communications, 1995
- Subunits of the regulatory complex of the 26S proteaseMolecular Biology Reports, 1995
- Proteasome components with reciprocal expression to that of the MHC-encoded LMP proteinsCurrent Biology, 1994